SSS cleanser

Manufacturer
PruGen Pharmaceuticals | Dermazone Solutions, Inc.
Effective date
2022-01-20
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:39:24

Label at a glance#

ProductSSS cleanser
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure12 sections

Dosage and administration

Apply SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) sooner or usin...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA.

DESCRIPTION

DESCRIPTION SECTION

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:

Chemical Structure
Chemical Structure

Each mL of SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) contains 100 mg of Sulfacetamide Sodium, USP and 10 mg of Sulfur in a formulation consisting of: Aloe Barbadensis Leaf Juice, Butylated Hydroxy Toluene, Camellia Sinensis Leaf Extract, Cetyl Alcohol, Disodium Oleamido MEA Sulfosuccinate, Edetate Disodium, Glyceryl Stearate, Magnesium Aluminum Silicate, Methylparaben, PEG-100 Stearate, Propylene Glycol, Propylparaben, Purified Water, Sodium Cocoyl Isethionate, Sodium Methyl Cocoyl Taurate, Sodium Thiosulfate, Stearyl Alcohol, White Petrolatum, Xanthan Gum.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS

INDICATIONS & USAGE SECTION

SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) is not to be used by patients with kidney disease.

WARNINGS

WARNINGS SECTION

Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of reach of children. Keep container tightly closed.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

Information for Patients

INFORMATION FOR PATIENTS SECTION

Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis and Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCY

PREGNANCY SECTION

Category C

SPL UNCLASSIFIED SECTION

Animal reproduction studies have not been conducted with SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%). It is also not known whether SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS

NURSING MOTHERS SECTION

It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%). However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) is administered to a nursing woman.

PEDIATRIC USE

PEDIATRIC USE SECTION

Safety and effectiveness in children under the age of 12 has not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Although rare, sodium sulfacetamide may cause local irritation.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Apply SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) sooner or using less often.

HOW SUPPLIED

HOW SUPPLIED SECTION

SSS 10-1 Cleanser (Sodium Sulfacetamide 10% & Sulfur 1%) is available in a 6 oz. (170.1g) tube, NDC 42546-174-06.

STORAGE AND HANDLING SECTION

Store at 20°C to 25°C (68°F to 77°F)

Protect from freezing.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

SPL UNCLASSIFIED SECTION

Manufactured for:
PruGen Pharmaceuticals
Scottsdale, AZ 85255

Rev. 1.0

PRINCIPAL DISPLAY PANEL - 170.1 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SSS
10-1
cleanser

Sodium
Sulfacetamide 10%
& Sulfur 1%

Rx only
Net Wt. 6 oz (170.1g)

NDC 42546-174-06

PRINCIPAL DISPLAY PANEL - 170.1 g Tube Carton
PRINCIPAL DISPLAY PANEL - 170.1 g Tube Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999604sulfacetamide sodium 10 % / sulfur 1 % Medicated Liquid SoapPSN2
999604sulfacetamide sodium 100 MG/ML / sulfur 10 MG/ML Medicated Liquid SoapSCD2
999604sulfacetamide sodium 10 % / sulfur 1 % Medicated Liquid SoapSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SULFACETAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
0304b7d2-7a07-d53b-750f-36012ae6612eProduct name120140508
64c0cc7e-6478-3ca1-8cd7-9a1251d5a3f6Product name120140508
9ae74339-0a3d-82e9-5dd1-88bd2607bd6bProduct name120140508
e44e38a9-2d9e-b0e2-cce9-490554639f3dProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42546-174-06SSS cleanser1 in 1 CARTONCREAM12
42546-174-06SSS cleanser170.1 g in 1 TUBECREAM170.12
42546-174-16SSS cleanser453.6 g in 1 BOTTLECREAM453.62
42546-174-16SSS cleanser1 in 1 CARTONCREAM12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42546-174SSS CLEANSER (SULFACETAMIDE SODIUM AND SULFUR) CREAM [PRUGEN PHARMACEUTICALS]2Legacy NDC, 4 package rows20220121_67430dff-39b0-4ae7-bf05-1263d4694103.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
42546-17442546-174-06, 42546-174-16

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
fe58f64b-6e83-4d3e-b775-16cae0b79f7267430dff-39b0-4ae7-bf05-1263d46941032022-01-20Warnings, Adverse reactionsExact identifier
spl id: fe58f64b-6e83-4d3e-b775-16cae0b79f72
spl set id: 67430dff-39b0-4ae7-bf05-1263d4694103

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.